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Caesarean scar pregnancy (csp) is arare and potentially dangerous type of ectopic pregnancy resulting from the implantation of 
an embryo within the area of a previous Caesarean 
section scar.1 It is a complication which can be 
attributed to the recent worldwide increase in 
Caesarean births.2 The early and accurate diagnosis of 
such cases is essential, as a CSP can be easily confused 
with an undetected/silent miscarriage, an incomplete 
miscarriage during the expulsion process or a cervical 
ectopic pregnancy.3
Due to the lack of reported data regarding CSPs, 
the true incidence of this complication is difficult to 
determine; studies have reported an incidence of one 
in 1,800 to one in 2,216 pregnancies.4–6 CSP has been 
found to represent 6.1% of all ectopic pregnancies 
where there is a history of at least one Caesarean 
section.6 CSP was first reported in the English medical 
literature in 1978.7 Only 19 cases were reported 
between 1966 and 2002; however, this number rose 
to 268 in the following eight years.1,8 The increase 
in reported CSP cases may have been influenced by 
the rise of Caesarean sections, along with the more 
widespread availability and well-defined criteria 
of the transvaginal scan which aids in the earlier 
detection of such pregnancies. Notwithstanding this 
recent development, current knowledge regarding 
the management of this potentially life-threatening 
condition continues to be based mainly on individual 
case reports and a small number of case series. Suction 
evacuation or primary curettage are often reported 
as the least favoured treatment options due to their 
associated complications.9,10 
This case series presents six patients with CSPs 
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abstract: Pregnancy resulting from the implantation of an embryo within a scar of a previous Caesarean 
section is extremely rare. The diagnosis and treatment of Caesarean scar pregnancies (CSPs) are challenging and 
the optimal course of treatment is still to be determined. We report a case series of six patients with CSPs who 
presented to the Royal Hospital in Muscat, Oman, between October 2012 and April 2014. All of the patients were 
successfully treated with systemic methotrexate and five patients underwent suction evacuation either before or 
after the methotrexate administration. The patients were followed up for a period of 6–9 weeks after treatment and 
recovered completely without any significant complications. Suction evacuation with methotrexate can therefore 
be considered an effective treatment option with good maternal outcomes. 
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امللخ�ص: احلمل الناجت عن غر�ض اجلنني داخل ندبة لعملية قي�رسية �سابقة حالة نادرة للغاية. ت�سخي�ض وعالج حالت احلمل يف الندبة 
القي�رسية �سعبة وال�سبيل الأمثل للعالج مل يتعني بعد. نعر�ض هنا �سل�سلة حالت ل�ستة ن�ساء يعانون من احلمل يف الندبة القي�رسية قدمن 
اإىل امل�ست�سفى امللكي يف م�سقط، عمان، بني اأكتوبر 2012 واأبريل 2014. مت عالج جميع املري�سات بنجاح با�ستخدام امليثوتريك�سيت العام 
اأ�سابيع بعد   6-9 اأو بعد العالج بامليثوتريك�سيت. متت متابعة املري�سات ملدة  وخ�سعت خم�سة من املري�سات لل�سفط الهوائي �سواء قبل 
العالج وال�سفاء التام دون اأي م�ساعفات خطرية. وبالتايل، ميكن اعتبار ال�سفط الهوائي مع امليثوتريك�سيت خيار عالجي فعال مع نتائج 
جيدة.
مفتاح الكلمات: احلمل خارج الرحم؛ عمليه قي�رسية؛ ندبة؛ �سفط كحت؛ امليثوتريك�سيت؛ �سل�سلة حالت؛ عمان.
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treated successfully with a combination of systemic 
methotrexate and suction evacuation at the Royal 
Hospital in Muscat, Oman, between October 2012 and 
April 2014. All patients consented to the publication of 
their anonymised data. 
Case 1
A 33-year–old woman was referred to the Royal 
Hospital in October 2012 at seven gestational weeks 
into her seventh pregnancy. She had had one lower 
segment Caesarean section five years previously, 
followed by a vaginal birth. At presentation, the 
patient had a three-day history of vaginal bleeding 
with clots and her β-human chorionic gonadotropin 
(β-hCG) level was 9,400 IU/L. A CSP was suspected 
[Figure 1] and she was referred to the Royal Hospital 
after receiving one intramuscular dose of 80 mg/m2 
of methotrexate the previous day. After undergoing 
counselling regarding her available treatment 
options—repeated administration of methotrexate 
or surgical evacuation—the patient opted for the 
latter modality. During the procedure, the patient lost 
200 mL of blood and a Foley catheter was inserted 
into the uterine cavity. The patient had an uneventful 
postoperative course; her β-hCG level dropped to 
3,336 IU/L after four days and she was discharged 
and followed up as an outpatient. After eight weeks, 
the patient’s β-hCG level was negative. The small 
haematoma in the scar site resolved after 12 weeks. 
Case 2
A 30-year-old woman presented to Royal Hospital 
in November 2013 at five gestational weeks into her 
third pregnancy with abdominal pain and mild vaginal 
bleeding. She had had two lower segment Caesarean 
sections in the past and a laparoscopic left ovarian 
cystectomy for a dermoid cyst 11 days previously. At 
presentation, her β-hCG level was 4,980 IU/L; however, 
this rose to 10,907 IU/L after 48 hours. An ultrasound 
scan suggested a CSP and this was later confirmed 
by magnetic resonance imaging (MRI). The patient 
received one dose of 50 mg/m2 of methotrexate when 
her β-hCG level reached 38,452 IU/L. She underwent 
a suction evacuation two days later during which she 
lost 700 mL of blood. The postoperative course was 
uneventful; her β-hCG level dropped to 3,867 IU/L 
after four days and she was discharged and followed up 
as an outpatient. Her β-hCG level was negative after 
eight weeks. The patient had an intrauterine pregnancy 
the following year which unfortunately resulted in 
early fetal death. She subsequently underwent another 
successful suction evacuation.
Case 3
A 35-year-old woman presented to the Royal Hospital 
in October 2013 at 11 gestational weeks into her fifth 
pregnancy with mild vaginal bleeding and pain. She 
had had a lower segment Caesarean section four years 
previously due to grade 3 anterior placenta praevia 
partially covering the internal opening of the cervix. 
A transvaginal scan showed a collapsed intrauterine 
gestational sac in the lower uterine segment with 
fetal pole and no fetal cardiac activity [Figure 2]. The 
patient’s β-hCG level was 12,971 IU/L. A diagnosis of 
a silent miscarriage was made and she received two 
doses of 800 µg of misoprostol. The patient underwent 
a suction evacuation two days later as she did not 
respond to the treatment. Although the patient lost 
500 mL of blood during the procedure and her 
haemoglobin dropped by 2 g%, she did not require a 
blood transfusion. 
The patient was discharged two days after the 
surgery but was readmitted 10 days later with heavy 
 
Figure 1: Vaginal ultrasound showing a pregnancy in 
the Caesarean scar site (white arrow) growing towards 
the endometrial cavity (arrowhead). The bladder can 
also be observed (red arrow).
 
Figure 2: Vaginal ultrasound of an empty endometrial 
cavity (blue arrow) and cervix (white arrow) with a 
pregnancy at the Caesarean scar site (black arrow). 
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Case 5
A 32-year-old woman with a history of three lower 
segment Caesarean sections was referred to the Royal 
Hospital in March 2014 at nine gestational weeks 
into her fourth pregnancy. She was referred due to 
a suspected silent miscarriage and molar pregnancy. 
She underwent a transvaginal scan which raised the 
suspicion of a CSP; this was later confirmed by MRI 
[Figure 4]. Her β-hCG level was 25,261 IU/L and she 
received one dose of 50 mg/m2 of methotrexate. 
At a follow-up appointment one week later, her 
β-hCG level was 5,389 IU/L and she received a second 
dose of 50 mg/m2 of methotrexate. She then developed 
vaginal bleeding and underwent an emergency 
evacuation of the uterus, during which she lost 
1,000 mL of blood. An intrauterine Foley catheter 
was inserted and uterine artery embolisation (UAE) 
was performed. Four days after surgery, her β-hCG 
level decreased significantly to 1,049 IU/L; it became 
negative after five weeks and the patient recovered well. 
Case 6
A 39-year-old woman was referred to the Royal 
Hospital in April 2014 at 11 gestational weeks 
into her fifth pregnancy with a suspected silent 
miscarriage. She had a history of four previous lower 
segment Caesarean sections. She received three 800 
µg doses of misoprostol but failed to respond to the 
treatment. A CSP was suspected and was confirmed 
by transvaginal scan. A combined transvaginal and 
transabdominal scan of the patient with a full bladder 
was performed. The patient received one dose of 
50 mg/m2 of methotrexate. The subsequent follow-up 
period showed a decline in her β-hCG level to <1 IU/L 
bleeding. A CSP was suspected following an ultra-
sound and confirmed by MRI; a morbidly adherent 
placenta and haematoma formation in the anterior wall 
was also observed. Her β-hCG level was 1,741 IU/L 
and she was given one dose of 50 mg/m2 of 
methotrexate. She was followed up as an outpatient. 
Her β-hCG level was negative after 10 weeks; however, 
the haematoma persisted for four months. The patient 
was advised to undergo an early elective lower segment 
Caesarean section at 37–38 gestational weeks during 
her next pregnancy. 
Case 4
A 40-year-old woman was referred to the Royal 
Hospital in December 2013 at 16 gestational weeks 
into her sixth pregnancy with a diagnosis of a silent 
miscarriage. She had had three previous Caesarean 
sections, the last one occurring during the previous 
year. She received three doses of 800 µg of misoprostol 
and then opted for surgical evacuation. She bled 
2,500 mL during the evacuation and required 
tamponade by a Foley catheter in the uterine cavity. 
The patient received two units of blood with six units 
of fresh frozen plasma. The uterine Foley catheter 
was removed after 24 hours and the patient was 
subsequently discharged.
The patient was readmitted one week later with 
heavy vaginal bleeding. A CSP was suspected and then 
confirmed by MRI [Figure 3]. Her β-hCG level was 
15 IU/L and she was given one dose of 50 mg/m2 of 
methotrexate. After four weeks, during a subsequent 
outpatient follow-up appointment, it was noted that 
her β-hCG level had returned to negative and the 
residual pregnancy mass in the anterior uterine wall 
had resolved. 
 
Figure 3: Magnetic resonance image of the pelvis 
showing a Caesarean scar pregnancy (white arrow) with 
an empty but dilated endometrial cavity (arrowhead). 
The bladder can also be observed (red arrow).  
 
Figure 4: Magnetic resonance image of the pelvis 
showing a scar pregnancy (white arrow) with an empty 
endometrial canal and cervix (arrowhead). 
Suction Evacuation with Methotrexate as a Successful Treatment Modality for Caesarean Scar Pregnancies 
Case series
e542 | SQU Medical Journal, November 2015, Volume 15, Issue 4
after five weeks. The pregnancy mass had resolved 
after four weeks. 
Clinical and treatment details for each patient are 
presented in Table 1. Overall findings for the case series 
are presented in Table 2. Histopathology results for all 
patients showed products of conception. Outpatient 
follow-up included weekly checks of serum β-hCG 
levels until the values had returned to normal. Weekly 
ultrasound scans were performed until the CSP had 
resolved completely. All of the women recovered 
completely with no methotrexate-related side-effects 
and no additional medical or surgical interventions. 
Those who were planning further pregnancies were 
advised regarding the optimal timeframe for their next 
pregnancy and were encouraged to have early vaginal 
scans during their next pregnancy to confirm the 
intrauterine location of the embryo. 
Discussion 
There has been a rise in the reported incidence of CSP 
in the medical literature in recent years.2 Although 
a series of 18 and eight CSP cases were reported by 
Jurkovic et al. and Maymon et al., respectively, the 
majority of data on CSP are found in individual case 
reports or small case series.4,11 To the best of the authors’ 
knowledge, this is the first case series to exclusively 
present suction evacuation and methotrexate as a 
treatment modality; this will hopefully aid in the 
acceptance of this approach as an effective treatment 
option for CSP. 
Vial et al. proposed two different types of CSP; the first 
occurs due to the implantation of the gestational sac on 
the scar with progression towards either the cervico-
isthmic space or uterine cavity and the second as a 
result of a deep implantation into a post-Caesarean 
section defect with growth towards the bladder.12 
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Sumita Datta and Chitra Jha
Case Series | e543
potential difficulties in achieving an accurate diagnosis 
at presentation. Early diagnosis is paramount in CSP to 
increase the number of available treatment options and 
to avoid serious complications like haemorrhage and 
uterine rupture. Many undiagnosed CSP patients present 
with heavy bleeding, shock and haemoperitoneum after 
the termination of an early pregnancy or dilatation 
following a silent miscarriage, as was the case in two of 
the patients in the current series.
Transvaginal ultrasonography has been reported 
as a first-line diagnostic tool, with a sensitivity rate 
of 86.4%.5 Sonographic criteria for diagnosing CSP 
include an empty uterus without contact with the 
gestational sac; a visibly empty cervical canal; the 
presence of the gestational sac with or without a 
fetal pole and with or without fetal cardiac activity 
(depending on the gestational age) in the anterior 
segment of the uterine isthmus; and the absence of 
or a defect in the myometrial tissue between the 
bladder and the gestational sac.1,7 All cases of CSP 
in the current series fulfilled these criteria. With 
transvaginal ultrasonography, a diagnosis of CSP can 
be confidentially made using a sagittal view along 
the long axis of the uterus through the gestational 
sac.7 Maymon et al. recommended a dual approach, 
combining transvaginal and transabdominal scans 
of the patient with a full bladder; the latter provides 
a ‘panoramic’ view of the uterus and an accurate 
measurement of the distance between the gestational 
sac and the bladder.11 This technique was used to 
diagnose CSP in one patient in the current case series, 
as the patient’s uterus was pulled up due to her four 
previous Caesarean surgeries. Another diagnostic 
method proposed by Jurkovic et al. is the negative 
sliding organ sign, defined as the inability to displace 
the gestational sac from its position at the level of the 
internal cervical opening using gentle pressure applied 
with a transabdominal probe.4
As yet, there is no proven relationship between 
the number of previous Caesarean sections, or the 
time interval between Caesarean sections, and the 
subsequent development of CSP. Jurkovic et al. found 
that 72.0% of their patients had previously had two or 
more Caesarean sections;4 a similar percentage was 
observed in the current case series, with 66.7% of the 
patients having previously had two or more Caesarean 
sections. Previous Caesarean section scars should be 
examined routinely during early pregnancy to help 
reduce the misdiagnosis of CSPs as silent miscarriages 
and to improve maternal morbidity and mortality.
In the absence of a standard treatment protocol 
for CSP, a number of treatment options exist, either 
singly or in combination, with varied success rates. 
Important factors influencing choice of treatment 
While the first type of pregnancy may result in a 
viable birth, it has an increased risk of life-threatening 
bleeding from the implantation site.7,13 The second 
generally leads to a rupture and bleeding during the 
first trimester.12
The clinical presentation of patients in the current 
case series reflects the wide range of symptoms 
associated with this rare kind of ectopic pregnancy. 
Symptoms varied from slight vaginal bleeding and 
pain to profuse vaginal bleeding and, ultimately, 
silent miscarriages. These cases therefore highlight the 
Table 2: Summary of the clinical characteristics, imaging 
modality, interventions and recovery of the six presented 
patients with Caesarean scar pregnancies
n (%)
Characteristics
Mean maternal age in years (range) 35 (30–40)
Gravidity (range) 5 (3–7)
Mean gestational age at diagnosis in weeks 
(range)
11 (5–16)
Spontaneous conception 6 (100.0)
History of LSCS 5 (83.3)
Imaging modality
Transvaginal ultrasonography 6 (100.0)
Transabdominal ultrasonography 1 (16.7)
Magnetic resonance imaging 4 (66.7)
Interventions
Blood transfusion 3 (50.0)
    •One unit 2 (33.4)
    •Two units 1 (16.7)
Systemic methotrexate 6 (100.0)
    •First-line followed by suction evacuation 3 (50.0)
    •First-line with no subsequent intervention
     required
1 (16.7)
    •Following evacuation 2 (33.4)*
Suction evacuation 5 (83.3)
UAE following suction evaluation 1 (16.7)
Recovery
Mean follow-up in weeks (range) 8 (6–9)
Full recovery 6 (100.0)
Methotrexate-related side-effects 0 (0.0)
Additional interventions 0 (0.0)
LSC = lower segment Caesarean section; UAE = uterine artery 
embolisation.
*These two patients underwent a suction evacuation for a missed/silent 
miscarriage before the correct diagnosis of CSP was made 
at readmission.
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include the clinical stability of the patient, gestational 
age, size of the ectopic pregnancy mass, β-hCG levels 
and any known contraindication to methotrexate 
therapy. All treatment regimens aim to resolve the 
CSP prior to rupture and preserve future fertility, 
if desired. In the literature, almost all of the women 
whose pregnancies were managed expectantly 
developed placenta accreta or increta, resulting 
in either a hysterotomy or hysterectomy with 
severe haemorrhage.7 The pathophysiology of scar 
implantation has been suggested as a precursor of 
placenta accreta.14 Therefore, most diagnosed cases 
are treated by either surgical or medical means or a 
combination of both. Suggested medical treatments 
involve the administration of local intragestational 
methotrexate; systemic methotrexate; potassium 
chloride; hyperosmolar glucose; or a combined 
approach with varying regimens.15–17
Fadhlaoui et al. reported the combination of 
medical modalities, either systemic or local and as a 
single agent or a combined regimen, with aspiration of 
the gestational sac.18 This approach can preserve fertility 
and avoid an unnecessary laparotomy; however, it 
requires close monitoring and follow-up of the patient 
as the normalisation of β-hCG levels may take up to 
4–16 weeks.15,16,19 In their analysis of published case 
reports, Jurkovic et al. found that medical treatment 
with methotrexate was successful in 71.0–80.0% of 
cases, with 6.0% of women requiring a hysterectomy.4 
To date, 17 cases of CSP involving uterine 
curettage as the primary therapy have been reported 
in the medical literature.9,10,20 Arslan et al. reported 
unsuccessful or complicated uterine curettage in 
eight out of nine women,9 whereas Wang et al. 
reported a failure rate of 70.0% after curettage.20 This 
could be attributed to an inability to evacuate all of 
the ectopic tissue and the increased risk of uterine 
rupture and severe haemorrhage.20 However, some 
reports have suggested that dilatation and curettage 
should be considered in cases with early presentation 
(<7 gestational weeks) and in those with sufficient 
myometrial tissue between the gestational sac 
and the bladder (>3.5 mm).9,18,20 Additional adjunct 
and haemostatic measures—such as vasopressin, 
intrauterine balloon tamponade with a Foley catheter, 
bilateral UAE and bilateral uterine artery ligation—have 
been used for the prevention and control of profuse 
bleeding in a variety of treatment settings.4,21–23
Minimally invasive treatment modalities are 
usually determined by the type of CSP, with a 
laparoscopic approach being suitable for deeply 
implanted pregnancies growing towards the 
abdominal cavity, while a hysteroscopic approach 
may be considered in those growing towards the 
uterine cavity. Hysteroscopic evacuations have 
been reported by Wang et al. and Chao et al. after 
failed curettage and methotrexate treatment.24,25 
Laparoscopic removal of the CSP and laparoscopi-
cally-assisted operative hysteroscopy have also been 
reported as treatment options in cases where the 
patient is stable and appropriate facilities with a trained 
surgeon are available.26,27 Surgical treatment, either a 
laparotomy with wedge resection or a hysterectomy, 
should be considered in haemodynamically unstable 
patients with late presentation of the CSP, those 
presenting with uterine rupture, in the event of 
failed medical/surgical treatment or for cases where 
operative endoscopy is not feasible. A laparotomy has 
the advantage of completely removing the CSP mass 
and repairing the scar at the same time, followed by 
the normalisation of β-hCG levels within 1‒2 weeks.1,11
Long-term complications following treatment of a 
CSP include fertility issues and recurrence. A follow-up 
study of 29 women who were successfully treated for 
CSP reported favourable reproductive outcomes and 
a low recurrence rate.28 Out of 24 women attempting 
to become pregnant, 21 conceived spontaneously (20 
intrauterine pregnancies and one recurrent CSP); of 
the intrauterine pregnancies, 13 were normal (nine 
of which were delivered by Caesarean section) while 
seven ended in spontaneous miscarriages.28 Using 
sonohysterography, the integrity of the uterine wall 
post-Caesarean section can be determined even in 
non-pregnant patients.2,29 Caesarean scar defects, 
defined by the presence of fluid within the incision site, 
or any filling defects at the presumed scar site might 
indicate uterine scar complications in a subsequent 
pregnancy.4,29 Counselling and treatment options for 
these patients should therefore be tailored accordingly. 
Conclusion
CSP is a potentially life-threatening complication 
following a previous Caesarean birth and an 
exponential rise in the incidence of this type of 
pregnancy has recently been recorded. Bleeding 
and pain in early pregnancy are the most common 
presenting symptoms. Examining the appearance of a 
previous Caesarean section scar should be a routine 
procedure in every early pregnancy to help reduce 
misdiagnosis and maternal morbidity and mortality. 
There is no general consensus on the most effective 
treatment modality for CSP; however, this case 
series shows that suction evacuation combined with 
methotrexate is a successful treatment option with 
good maternal outcome.
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